Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0UJUZQ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
GQ-1007
|
|||||
| Synonyms |
GQ 1007; GQ-1007; GQ1007
Click to Show/Hide
|
|||||
| Organization |
GeneQuantum Healthcare (Suzhou) Co. Ltd.; Borui Biomedical Technology (Suzhou) Co., Ltd.
|
|||||
| Drug Status |
Phase 1 (Terminated)
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
TLR7/8 agonist
|
Payload Info | ||||
| Therapeutic Target |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
|
Target Info | ||||
| Conjugate Type |
Undisclosed
|
|||||
